Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane pharmacokinetics during 48-hour ICU sedation with AnaConDa
2007-002925-64Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sevoflurane in critical illness, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Plasma sevoflurane concentrations and Pharmacokinetic profile of sevoflurane over 48 hours. Started Jun 2007; status: active.
02
Drugs
sevoflurane
03
Conditions
critical illness
Beyond the preview
Go deeper on 2007-002925-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002925-64.